CLI Vice Pres. Dr. Prentice on Gene-Editing: “Let Congress Know to Take It Slow”
|On December 28, 2016, CLI’s Vice President and Research Director, Dr. David Prentice, co-authored an op-ed with Congressman Dr. Michael Burgess (R-Tex.) on the ethical and unethical uses of human gene editing, especially in light of the advent of the CRISPR-Cas System.